In conclusion, this is the first study to investigate the gene expression, clinical features and biological functions of TRIM56 in gliomas by bioinformatics analysis techniques including bulk RNA-seq analysis and single-cell analysis. The gene discussed is TRIM56; the disease is central nervous system cancer.